FISHER ALAN enters NEUPHORIA THERAPEUTICS INC. with 100K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 7/8/2024ACC: 0001213900-24-059639
100K
Baseline shares
100% direct
100K
Direct ownership
1 position
300K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Ordinary Shares
DirectShares owned100K
Total
100K direct100K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 100K | Direct |
| Total | 100K | 100K direct |
Derivative Holdings3
Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100K
Shares owned
N/A
Exercise price
0.2349
Expiration
—
Exercise window
—
Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100K
Shares owned
N/A
Exercise price
0.2349
Expiration
—
Exercise window
—
Option (right to buy)
DirectUnderlying security
Ordinary Shares
Underlying shares
100K
Shares owned
N/A
Exercise price
0.2349
Expiration
—
Exercise window
—
Total
Underlying
300K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Ordinary Shares | 0.2349 | — | — | 100K | N/A |
| Option (right to buy) Direct | Ordinary Shares | 0.2349 | — | — | 100K | N/A |
| Option (right to buy) Direct | Ordinary Shares | 0.2349 | — | — | 100K | N/A |
| Total | 300K | 0.00 | ||||